17-7284083-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_001042.3(SLC2A4):c.558C>T(p.Ile186Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000394 in 1,613,506 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0018 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 1 hom. )
Consequence
SLC2A4
NM_001042.3 synonymous
NM_001042.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.11
Genes affected
SLC2A4 (HGNC:11009): (solute carrier family 2 member 4) This gene is a member of the solute carrier family 2 (facilitated glucose transporter) family and encodes a protein that functions as an insulin-regulated facilitative glucose transporter. In the absence of insulin, this integral membrane protein is sequestered within the cells of muscle and adipose tissue. Within minutes of insulin stimulation, the protein moves to the cell surface and begins to transport glucose across the cell membrane. Mutations in this gene have been associated with noninsulin-dependent diabetes mellitus (NIDDM). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 17-7284083-C-T is Benign according to our data. Variant chr17-7284083-C-T is described in ClinVar as [Benign]. Clinvar id is 713532.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.11 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00177 AC: 269AN: 152238Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
269
AN:
152238
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000557 AC: 139AN: 249448 AF XY: 0.000437 show subpopulations
GnomAD2 exomes
AF:
AC:
139
AN:
249448
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000250 AC: 366AN: 1461150Hom.: 1 Cov.: 34 AF XY: 0.000201 AC XY: 146AN XY: 726832 show subpopulations
GnomAD4 exome
AF:
AC:
366
AN:
1461150
Hom.:
Cov.:
34
AF XY:
AC XY:
146
AN XY:
726832
Gnomad4 AFR exome
AF:
AC:
224
AN:
33456
Gnomad4 AMR exome
AF:
AC:
25
AN:
44648
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26114
Gnomad4 EAS exome
AF:
AC:
0
AN:
39662
Gnomad4 SAS exome
AF:
AC:
1
AN:
86152
Gnomad4 FIN exome
AF:
AC:
9
AN:
53310
Gnomad4 NFE exome
AF:
AC:
48
AN:
1111680
Gnomad4 Remaining exome
AF:
AC:
48
AN:
60360
Heterozygous variant carriers
0
24
48
71
95
119
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00177 AC: 269AN: 152356Hom.: 1 Cov.: 32 AF XY: 0.00174 AC XY: 130AN XY: 74500 show subpopulations
GnomAD4 genome
AF:
AC:
269
AN:
152356
Hom.:
Cov.:
32
AF XY:
AC XY:
130
AN XY:
74500
Gnomad4 AFR
AF:
AC:
0.00591545
AN:
0.00591545
Gnomad4 AMR
AF:
AC:
0.000391952
AN:
0.000391952
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0.000282326
AN:
0.000282326
Gnomad4 NFE
AF:
AC:
0.000147007
AN:
0.000147007
Gnomad4 OTH
AF:
AC:
0.00189036
AN:
0.00189036
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 15, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at